Real-world effectiveness of oral antivirals for COVID-19.
Journal Information
Full Title: Lancet
Abbreviation: Lancet
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:
"CB reports consulting fees from Da Volterra and Mylan and from 4Living Biotech (member of a data safety monitoring board for a clinical trial [LEONARDO] to investigate the effect of plerixafor in acute respiratory failure related to COVID-19), which are all unrelated to the topic of this Comment. FA declares no competing interests."
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025